Category: U.S. Food and Drug Administration
Just as fly paper captures insects, an innovative new device with nano-sized features developed by researchers at UCLA is able to grab cancer cells in the blood that have broken off from a tumor.
Cold Spring Harbor, NY -- A team of scientists at Cold Spring Harbor Laboratory (CSHL) reports on Thursday their success in solving the molecular structure of a key portion of a cellular receptor i
November 11, 2009 (Oakland, Calif.) -- High levels of workplace exposure to Bisphenol-A may increase the risk of reduced sexual function in men, according to a Kaiser Permanente study appearing in
Reston, Va. -- SNM applauds the U.S. House of Representatives for its passage of H.R. 3276 -- the American Medical Isotopes Production Act of 2009.
BENLYSTA™ Successful in Second Pivotal Clinical Trial
LAKE ALFRED, FL -- Laser labeling of fruit and vegetables is a new, patented technology in which a low-energy carbon dioxide laser beam is used to label, or "etch" information on produce, thereby e
CINCINNATI -- The effectiveness of pandemic flu vaccination campaigns -- like that now underway for H1N1 -- could be undermined by the public incorrectly associating coincidental and unrelated h
HONOLULU - October 29, 2009 -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announced new study results on INTUNIV? (guanfacine) Extended Release Tablets, a
WASHINGTON -- The National School Lunch Program and the School Breakfast Program should adopt a new set of nutrient targets and standards for menu planning, says a new report from the Institute of Medicine. The recommended targets and standards would update and improve the programs' abilities to meet children's nutritional needs and foster healthy eating habits.
The development of new and innovative pharmaceuticals is being stifled by a U.S. law and successful patent challenges that embolden generic competition, according to an article published in this week's issue of the journal Science.
ST. PAUL, Minn. -- New guidelines from the American Academy of Neurology identify the most effective treatments for amyotrophic lateral sclerosis (ALS), often called Lou Gehrig's disease. The guidelines are published in the October 13, 2009, issue of Neurology®, the medical journal of the American Academy of Neurology.
An outbreak of bloodstream infections appears to have been caused by the contamination of pre-filled heparin and saline syringes made by a single company, according to a report in the October 12 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
